Hypertension Prevention in Pre-Hypertensive Individuals

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 730 participants.

Also called NCT00970931

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 730 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00970931
Other papers using this trial's data
  • Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial Journal of the American Heart Association, 2016-12-13 DOI, PubMed 27965209, PMC5210423 In the PMC Open Access subset under CC BY-NC-ND.
  • Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial Journal of hypertension, 2018-04 DOI, PubMed 29227377

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00970931. Randomized; quadruple masking; primary purpose prevention. Start 2010-07 (registry gives no type); primary completion 2014-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hypertension Prevention in Pre-Hypertensive Individuals
Acronym
PREVER
Condition
Pre-hypertension
Condition
Hypertension
Condition
Cardiovascular Disease
Intervention (Drug)
Chlorthalidone plus amiloride
Intervention (Drug)
placebo
Lead sponsor
Hospital de Clinicas de Porto Alegre (class: other)
Collaborator
Financiadora de Estudos e Projetos (class: other)

Record details

Record id
cardio:ct-nct00970931
Content hash
6c9b46dcd6798cb7a8c060a0b1c0cb617d22ac5a395b7590dd80c767ca03d837